R. Hoyt

发表

Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre‐transplant FDG‐PET scan following salvage chemotherapy

J. Szer, A. Roberts, H. Prince, 2010, British journal of haematology.

55 patients with myeloproliferative disorders in EP300 and MYB More on Myb in myelofibrosis: molecular analyses of

W. Alexander, D. Hilton, J. Szer, 2011 .

More on Myb in myelofibrosis: molecular analyses of MYB and EP300 in 55 patients with myeloproliferative disorders.

W. Alexander, D. Hilton, J. Szer, 2006, Blood.

Genetic heterogeneity of granulocytes for the JAK2 V617F mutation in essential thrombocythaemia: implications for mutation detection in peripheral blood

W. Alexander, J. Szer, A. Roberts, 2006, Pathology.

Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders

J. Szer, A. Roberts, K. Bradstock, 2006, Bone Marrow Transplantation.

Morphological effects of imatinib mesylate (STI571) on the bone marrow and blood of patients with Philadelphia chromosome (Ph) positive chronic myeloid leukaemia.

J. Szer, A. Grigg, C. McNamara, 2003, Clinical and laboratory haematology.

Etoposide induces more severe mucositis than CY when added to TBI as conditioning in allograft recipients receiving CsA and MTX

J. Szer, D. Ritchie, A. Grigg, 2010, Bone Marrow Transplantation.

The hyper-CVAD–rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma

J. Szer, A. Roberts, H. Prince, 2006, Annals of Hematology.

Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants

J. Szer, A. Roberts, D. Curtis, 2008, Bone Marrow Transplantation.

The effect of folinic acid on methylenetetrahydrofolate reductase polymorphisms in methotrexate-treated allogeneic hematopoietic stem cell transplants.

J. McCluskey, J. Szer, R. Holdsworth, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipients

S. Harrison, D. Ritchie, A. Grigg, 2018, Annals of Hematology.

Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCR

L. To, A. Trickett, D. Ma, 2003, Leukemia.

Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells

J. Szer, A. Grigg, R. Hoyt, 2000, Bone Marrow Transplantation.

Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate

J. McCluskey, J. Szer, B. King, 2006, Bone Marrow Transplantation.

The incidence, pathogenesis and natural history of steatorrhoea after bone marrow transplantation

J. Szer, A. Grigg, R. Hoyt, 2003, Bone Marrow Transplantation.